Playlist


Migration Crisis in Ceuta: Nearly 49,000 Migrants Enter Spanish Enclave in a Single Day
31 Jul. 16:40The Spanish enclave of Ceuta, located on the North African coast, has been overwhelmed by an unprecedented wave of migration. According to data provided by the Ministry of the Interior of Spain, approximately 49,000 individuals arrived in the territory via maritime and overland routes within a single 24-hour period. For context, the total resident population of Ceuta is roughly 84,000.
As reported by The Telegraph, the influx of migrants from Morocco follows a recent ruling by the Supreme Court of Spain. The judicial decision prohibits the immediate deportation of migrants intercepted at sea while attempting to reach Ceuta or neighboring Melilla. The expedited pushback procedure now applies solely to those illegally crossing the land border, which remains secured by 10-meter-high barriers and reinforced security forces.
Reports indicate that at least 18 individuals lost their lives during the border crossing attempts. To restore order and enhance security, Spanish authorities deployed additional military units to the region, with Prime Minister Pedro Sánchez expected to visit the area shortly.
The crisis triggered a sharp international reaction across Europe: Italian Prime Minister Giorgia Meloni and Foreign Minister Antonio Tajani called for the temporary suspension of Spain from the Schengen Area. In response, Spanish Foreign Minister José Manuel Albares accused Italian officials of political demagoguery and summoned the Italian ambassador for clarification, asserting that the situation stems from a court ruling rather than executive policy.


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.